S4E4: Samantha Sandler from SpringWorks Therapeutics on Building an IR Program For Long-Term Success

Winning IR

We see a lot of discussions and questions about how to build an IR program from the ground up–especially one that is adaptive and built for long-term success. In this episode of Winning IR, Mark Fasken sits down with Samantha Hilson Sandler, Head of Investor Relations at SpringWorks Therapeutics, about her experience building an IR program from the ground up. Samantha shares insights from her diverse background in healthcare and corporate investment banking and offers practical advice for new IROs on prioritization, investor targeting, and adapting strategies through the company’s transition from clinical to commercial stage.

Listen to the full episode to learn more about:

• Aligning the IR program with corporate strategy
• Building an IR program from scratch
• Engaging with leadership and stakeholders
• Defining IR strategy and objectives
• Effective communication and market insights
• Leveraging tools and technologies
• Investor targeting and prioritizing investor outreach
• Transitioning from clinical to commercial stage

Winning IR is brought to you by Irwin.
For more winning ideas, subscribe to Winning IR wherever you get your podcasts.
For more information, visit getirwin.com/winning-ir

Chapters

1. Samantha Sandler (00:00:00)

2. Introduction and Background (00:01:12)

3. Aligning IR Program with Corporate Strategy (00:01:51)

4. Building the IR Program from Scratch (00:02:54)

5. Engaging with Leadership and Stakeholders (00:03:21)

6. Defining IR Strategy and Objectives (00:03:49)

7. Initial Challenges and Organic Growth (00:05:29)

8. Effective Communication and Market Insights (00:06:37)

9. Identifying Key Stakeholders (00:08:49)

10. Leveraging Tools and Technology (00:15:42)

11. Prioritizing Investor Outreach (00:17:50)

12. Evaluating Success and KPIs (00:20:52)

13. Transitioning from Clinical to Commercial Stage (00:28:03)

14. Conclusion and Final Thoughts (00:31:38)